<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7118659\results\search\drugs\results.xml">
  <result pre="10.1016/j.ijantimicag.2020.105938105938 : Article New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19? DevauxChristian A.christian.devaux@mediterranee-infection.comabc�?�RolainJean-MarcacColsonPhilippeacRaoultDidierac[a],"/>
  <result pre="potent inhibitor of most coronaviruses, including SARS-CoV-1. Preliminary trials of" exact="chloroquine" post="repurposing in the treatment of COVID-19 in China have"/>
  <result pre="several new trials. Here we discuss the possible mechanisms of" exact="chloroquine" post="interference with the SARS-CoV-2 replication cycle. Keywords COVID-19 SARS-CoV-2"/>
  <result pre="the previous drug of choice against malaria [3]. For decades," exact="chloroquine" post="was a front-line drug for the treatment and prophylaxis"/>
  <result pre="most prescribed drugs worldwide [4]. Chloroquine and the 4-aminoquinoline drug" exact="hydroxychloroquine" post="belong to the same molecular family. Hydroxychloroquine differs from"/>
  <result pre="hydroxychloroquine belong to the same molecular family. Hydroxychloroquine differs from" exact="chloroquine" post="by the presence of a hydroxyl group at the"/>
  <result pre="molecule is available for oral administration in the form of" exact="hydroxychloroquine" post="sulfate. Hydroxychloroquine has pharmacokinetics similar to that of chloroquine,"/>
  <result pre="of these drugs slightly differ. In malaria, the indication for" exact="chloroquine" post="was a high dose for a short period of"/>
  <result pre="of time. Hydroxychloroquine was reported to be as active as" exact="chloroquine" post="against Plasmodium falciparum malaria and less toxic, but it"/>
  <result pre="and less toxic, but it is much less active than" exact="chloroquine" post="against chloroquine-resistant P. falciparum owing to its physicochemical properties."/>
  <result pre="falciparum owing to its physicochemical properties. What is advantageous with" exact="hydroxychloroquine" post="is that it can be used in high doses"/>
  <result pre="long periods with very good tolerance. Unfortunately, the efficacy of" exact="chloroquine" post="gradually declined due to the continuous emergence of chloroquine-resistant"/>
  <result pre="tolerability, rare toxicity reports, inexpensive cost and immunomodulatory properties [11]," exact="chloroquine" post="repurposing was explored against human immunodeficiency virus (HIV) and"/>
  <result pre="possibility of a SARS-CoV-2 pandemic, the broad-spectrum antiviral effects of" exact="chloroquine" post="warranted particular attention for repurposing this drug in the"/>
  <result pre="SARS-CoV-2, named coronavirus disease 2019 (COVID-19). 2 Antiviral properties of" exact="chloroquine" post="In vitro, chloroquine appears as a versatile bioactive agent"/>
  <result pre="disease 2019 (COVID-19). 2 Antiviral properties of chloroquine In vitro," exact="chloroquine" post="appears as a versatile bioactive agent reported to possess"/>
  <result pre="virus [40] and herpes simplex virus [41].The antiviral properties of" exact="chloroquine" post="described in vitro have sometimes been confirmed during treatment"/>
  <result pre="in clinical trials depending on the disease, the concentration of" exact="chloroquine" post="used, the duration of treatment and the clinical team"/>
  <result pre="of the trial. Regarding coronaviruses, the potential therapeutic benefits of" exact="chloroquine" post="were notably reported for SARS-CoV-1 [11,42]. Chloroquine was also"/>
  <result pre="mice with the HCoV-O43 coronavirus could be averted by administering" exact="chloroquine" post="through the mother's milk. In vitro experiments also showed"/>
  <result pre="In vitro experiments also showed a strong antiviral effect of" exact="chloroquine" post="on a recombinant HCoV-O43 coronavirus [45]. Although chloroquine was"/>
  <result pre="effect of chloroquine on a recombinant HCoV-O43 coronavirus [45]. Although" exact="chloroquine" post="was reported to be active against Middle East respiratory"/>
  <result pre="this observation remains controversial [47]. 3 Potential antiviral effect of" exact="chloroquine" post="against SARS-CoV-2 Because of its broad spectrum of action"/>
  <result pre="any known efficient therapy to investigate the possible effect of" exact="chloroquine" post="against SARS-CoV-2. A recent paper reported that both chloroquine"/>
  <result pre="of chloroquine against SARS-CoV-2. A recent paper reported that both" exact="chloroquine" post="and the antiviral drug remdesivir inhibited SARS-CoV-2 in vitro"/>
  <result pre="Recently, the China National Center for Biotechnology Development indicated that" exact="chloroquine" post="is one of the three drugs with a promising"/>
  <result pre="Chinese authorities suggesting that approximately 100 infected patients treated with" exact="chloroquine" post="experienced a more rapid decline in fever and improvement"/>
  <result pre="serious adverse effects, the Chinese medical advisory board has suggested" exact="chloroquine" post="inclusion in the SARS-CoV-2 treatment guidelines. As a result,"/>
  <result pre="chloroquine inclusion in the SARS-CoV-2 treatment guidelines. As a result," exact="chloroquine" post="is probably the first molecule to be used in"/>
  <result pre="this drug in malaria therapy demonstrates the safety of acute" exact="chloroquine" post="administration to humans, one cannot ignore the minor risk"/>
  <result pre="reports on cardiomyopathy as a severe adverse effect caused by" exact="chloroquine" post="[53,54]. A survey of SARS-CoV-2-infected patients for adverse effects"/>
  <result pre="[53,54]. A survey of SARS-CoV-2-infected patients for adverse effects of" exact="chloroquine" post="therapy remains to be performed. However, chloroquine is currently"/>
  <result pre="adverse effects of chloroquine therapy remains to be performed. However," exact="chloroquine" post="is currently among the best available candidates to impact"/>
  <result pre="in humans. Currently, at least ten clinical trials are testing" exact="chloroquine" post="as an anti-COVID-19 therapy [55]. 4 Mode of action"/>
  <result pre="as an anti-COVID-19 therapy [55]. 4 Mode of action of" exact="chloroquine" post="Chloroquine has multiple mechanisms of action that may differ"/>
  <result pre="are critical components of ligand recognition. The possible interference of" exact="chloroquine" post="with sialic acid biosynthesis could account for the broad"/>
  <result pre="acid moieties as receptors [58]. The potent anti-SARS-CoV-1 effects of" exact="chloroquine" post="in vitro were considered attributable to a deficit in"/>
  <result pre="or Chikungunya virus [60,61]. Due to the alkalisation of endosomes," exact="chloroquine" post="was an effective in vitro treatment against Chikungunya virus"/>
  <result pre="require a low pH. For HIV, the antiretroviral effect of" exact="chloroquine" post="is attributable to a post-transcriptional inhibition of glycosylation of"/>
  <result pre="infectivity is impaired. In the herpes simplex virus (HSV) model," exact="chloroquine" post="inhibited budding with accumulation of non-infectious HSV-1 particles in"/>
  <result pre="site of virion budding [67], suggesting a possible action of" exact="chloroquine" post="on SARS-CoV-2 at this step of the replication cycle."/>
  <result pre="[68]. Beside affecting the virus maturation process, pH modulation by" exact="chloroquine" post="can impair the proper maturation of viral protein [32]"/>
  <result pre="endosomal acidification [69]. On the contrary, other proposed effects of" exact="chloroquine" post="on the immune system include increasing the export of"/>
  <result pre="[70]. In the influenza virus model, it was reported that" exact="chloroquine" post="improve the cross-presentation of non-replicating virus antigen by dendritic"/>
  <result pre="receptor was also reported in U937 monocytic cells treated with" exact="chloroquine" post="[84]. In the Dengue virus model, chloroquine was found"/>
  <result pre="cells treated with chloroquine [84]. In the Dengue virus model," exact="chloroquine" post="was found to inhibit interferon-alpha (IFNα), IFNβ, IFNγ, TNFα,"/>
  <result pre="replication of several coronaviruses. Recent publications support the hypothesis that" exact="chloroquine" post="can improve the clinical outcome of patients infected by"/>
  <result pre="patients infected by SARS-CoV-2. The multiple molecular mechanisms by which" exact="chloroquine" post="can achieve such results remain to be further explored."/>
  <result pre="SARS-CoV-1 [85,86] (Table 1 ), it may be hypothesised that" exact="chloroquine" post="also interferes with ACE2 receptor glycosylation thus preventing SARS-CoV-2"/>
  <result pre="on some cell subtypes, this interaction will be affected by" exact="chloroquine" post="treatment [87,88]. Today, preliminary data indicate that chloroquine interferes"/>
  <result pre="affected by chloroquine treatment [87,88]. Today, preliminary data indicate that" exact="chloroquine" post="interferes with SARS-CoV-2 attempts to acidify the lysosomes and"/>
  <result pre="molecular crosstalk with its target cell can be altered by" exact="chloroquine" post="through inhibition of kinases such as MAPK. Chloroquine could"/>
  <result pre="[98]. Fig. 1 Schematic representation of the possible effects of" exact="chloroquine" post="on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"/>
  <result pre="vesicles and are released by exocytosis. It is possible that" exact="chloroquine" post="interferes with ACE2 receptor glycosylation, thus preventing SARS-CoV-2 binding"/>
  <result pre="of SARS-CoV-2. If binding of some viral particles is achieved," exact="chloroquine" post="may modulate the acidification of endosomes thereby inhibiting formation"/>
  <result pre="autophagosome. Through reduction of cellular mitogen-activated protein (MAP) kinase activation," exact="chloroquine" post="may also inhibit virus replication. Moreover, chloroquine could alter"/>
  <result pre="(MAP) kinase activation, chloroquine may also inhibit virus replication. Moreover," exact="chloroquine" post="could alter M protein maturation and interfere with virion"/>
  <result pre="virion assembly and budding. With respect to the effect of" exact="chloroquine" post="on the immune system, see the elegant review by"/>
  <result pre="of us emphasised in this journal the possibility of using" exact="chloroquine" post="to fight orphan viral infections [10]. The worldwide ongoing"/>
  <result pre="our institute [90], will verify whether the hopes raised by" exact="chloroquine" post="in the treatment of COVID-19 can be confirmed. References"/>
  <result pre="research in the post-genomic eraNature455200875175618843360 2ParhizgarA.R.TahghighiA.Introducing new antimalarial analogues of" exact="chloroquine" post="and amodiaquine: a narrative reviewIran J Med Sci42201711512828360437 3editorBruce-ChwattL.J.Chemotherapy"/>
  <result pre="of SLE and lupus nephritisNat Rev Nephrol7201171872910.1038/nrneph.2011.15022009248 7RaoultD.DrancourtM.VestrisG.Bactericidal effect of" exact="doxycycline" post="associated with lysosomotropic agents on Coxiella burnetii in P388D1"/>
  <result pre="8RaoultD.HoupikianP.TissotD.H.RissJ.M.Arditi-DjianeJ.BrouquiP.Treatment of Q fever endocarditis: comparison of 2 regimens containing" exact="doxycycline" post="and ofloxacin or hydroxychloroquineArch Intern Med159199916717310.1001/archinte.159.2.1679927100 9BoulosA.RolainJ.M.RaoultD.Antibiotic susceptibility of"/>
  <result pre="Q fever endocarditis: comparison of 2 regimens containing doxycycline and" exact="ofloxacin" post="or hydroxychloroquineArch Intern Med159199916717310.1001/archinte.159.2.1679927100 9BoulosA.RolainJ.M.RaoultD.Antibiotic susceptibility of Tropheryma whipplei"/>
  <result pre="of Tropheryma whipplei in MRC5 cellsAntimicrob Agents Chemother48200474775214982759 10RolainJ.M.ColsonP.RaoultD.Recycling of" exact="chloroquine" post="and its hydroxyl analogue to face bacterial, fungal and"/>
  <result pre="infection in the 21st centuryInt J Antimicrob Agents30200729730817629679 11SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of" exact="chloroquine" post="on viral infections: an old drug against today's diseases?Lancet"/>
  <result pre="drug against today's diseases?Lancet Infect Dis3200372272714592603 12BoelaertJ.R.PietteJ.SperberK.The potential place of" exact="chloroquine" post="in the treatment of HIV-1-infected patientsJ Clin Virol20200113714011166662 13HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical"/>
  <result pre="potential bat origin. bioRxiv2020 Jan 23. doi:10.1101/2020.01.22.914952. 16TsiangH.SupertiF.Ammonium chloride and" exact="chloroquine" post="inhibit rabies virus infection in neuroblastoma cellsArch Virol8119843773826148053 17KronenbergerP.VrijsenR.BoeyéA.Chloroquine"/>
  <result pre="Retroviruses6199048148910.1089/aid.1990.6.4811692728 19SavarinoA.GenneroL.SperberK.BoelaertJ.R.The anti-HIV-1 activity of chloroquineJ Clin Virol20200113113511166661 20RomanelliF.SmithK.M.HovenA.D.Chloroquine and" exact="hydroxychloroquine" post="as inhibitors of human immunodeficiency virus (HIV-1) activityCurr Pharm"/>
  <result pre="A virus uncoatingIntervirology41199826127110325536 23MizuiT.YamashinaS.TanidaI.TakeiY.UenoT.SakamotoN.Inhibition of hepatitis C virus replication by" exact="chloroquine" post="targeting virus-associated autophagyJ Gastroenterol45201019520319760134 24MillerD.K.LenardJ.Antihistaminics, local anesthetics, and other"/>
  <result pre="a randomised, double-blind, placebo controlled trialLancet Infect Dis11201167768321550310 28YanY.ZouZ.SunY.LiX.XuK.F.WeiY.Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
  <result pre="an animal modelCell Res23201330030210.1038/cr.2012.16523208422 29De LamballerieX.BoissonV.ReynierJ.C.EnaultS.CharrelR.N.FlahaultA.On Chikungunya acute infection and" exact="chloroquine" post="treatmentVector Borne Zoonotic Dis8200883784010.1089/vbz.2008.004918620511 30KhanM.SanthoshS.R.TiwariM.Lakshmana RaoP.V.ParidaM.Assessment of in vitro"/>
  <result pre="30KhanM.SanthoshS.R.TiwariM.Lakshmana RaoP.V.ParidaM.Assessment of in vitro prophylactic and therapeutic efficacy of" exact="chloroquine" post="against Chikungunya virus in Vero cellsJ Med Virol82201081782420336760 31DeloguI.de"/>
  <result pre="virus in Vero cellsJ Med Virol82201081782420336760 31DeloguI.de LamballerieX.Chikungunya disease and" exact="chloroquine" post="treatmentJ Med Virol8320111058105921503920 32RandolphV.B.WinklerG.StollarV.Acidotropic amines inhibit proteolytic processing of"/>
  <result pre="to identification of a promising candidate for therapyJ Virol8320095148515519264786 37FreibergA.N.WorthyM.N.LeeB.HolbrookM.R.Combined" exact="chloroquine" post="and ribavirin treatment does not prevent death in a"/>
  <result pre="of a promising candidate for therapyJ Virol8320095148515519264786 37FreibergA.N.WorthyM.N.LeeB.HolbrookM.R.Combined chloroquine and" exact="ribavirin" post="treatment does not prevent death in a hamster model"/>
  <result pre="RembertA.Paranhos-BaccalaG.Evaluation of Crimean–Congo hemorrhagic fever virus in vitro inhibition by" exact="chloroquine" post="and chlorpromazine, two FDA approved moleculesAntiviral Res1182015758110.1016/j.antiviral.2015.03.00525796972 39DowallS.D.BosworthA.WatsonR.BewleyK.TaylorI.RaynerE.Chloroquine inhibited"/>
  <result pre="1 by ammonium chloride and chloroquineVirology13819843323356093369 42KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob Agents"/>
  <result pre="the endo-/lysosomal pathway in a proteolysis-dependent mannerPLoS Pathog102014e1004502 49WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="the recently emerged novel coronavirus (2019-nCoV) in vitroCell Res30202026927110.1038/s41422-020-0282-032020029 50GaoJ.TianZ.YangX.Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
  <result pre="of Guangdong Province and Health Commission of Guangdong Province for" exact="chloroquine" post="in the treatment of novel coronavirus pneumoniaExpert consensus on"/>
  <result pre="chloroquine in the treatment of novel coronavirus pneumoniaExpert consensus on" exact="chloroquine" post="phosphate for the treatment of novel coronavirus pneumonia [in"/>
  <result pre="Xi Za Zhi432020E01910.3760/cma.j.issn.1001-0939.2020.001932075365 52BernsteinH.N.Ocular safety of hydroxychloroquineAnn Ophthalmol2319912922961952638 53RatliffN.B.EstesM.L.MylesJ.L.ShireyE.K.McMahonJ.T.Diagnosis of" exact="chloroquine" post="cardiomyopathy by endomyocardial biopsyN Engl J Med31619871911933796692 54CuberoG.J.Rodriguez RegueroJ.J.Rojo"/>
  <result pre="coronavirus infection and spreadVirol J220056910.1186/1743-422X-2-6916115318 60TricouV.MinhN.N.VanT.P.LeeS.J.FarrarJ.WillsB.A randomized controlled trial of" exact="chloroquine" post="for the treatment of dengue in Vietnamese adultsPLoS Negl"/>
  <result pre="T cell-mediated immune responses to whole inactivated influenza virus by" exact="chloroquine" post="treatment in vivoVaccine3120131717172410.1016/j.vaccine.2013.01.03723380456 72SteizM.ValbrachtJ.QuachJ.LotzM.Gold sodium thiomalate and chloroquine inhibit"/>
  <result pre="virus by chloroquine treatment in vivoVaccine3120131717172410.1016/j.vaccine.2013.01.03723380456 72SteizM.ValbrachtJ.QuachJ.LotzM.Gold sodium thiomalate and" exact="chloroquine" post="inhibit cytokine production in monocytic THP-1 cells through distinct"/>
  <result pre="proinflammatory cytokine levels in systemic lupus erythematosus patientsLupus15200626827516761500 78SharmaO.P.Effectiveness of" exact="chloroquine" post="and hydroxychloroquine in treating selected patients with sarcoidosis with"/>
  <result pre="levels in systemic lupus erythematosus patientsLupus15200626827516761500 78SharmaO.P.Effectiveness of chloroquine and" exact="hydroxychloroquine" post="in treating selected patients with sarcoidosis with neurological involvementArch"/>
  <result pre="the SARS-coronavirus spike-protein for cell–cell and virus–cell fusionVirology413201126527410.1016/j.virol.2011.02.02021435673 90ColsonP.RolainJ.M.LagierJ.C.BrouquiP.RaoultD.Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19Int J Antimicrob Agents2020"/>
 </snippets>
</snippetsTree>
